meddevicedb.com FDA Device Reference

Catalyft PL Expandable Interbody System

K210425 Class II Traditional
Decision Date
2021-05-24
Sponsor / Applicant
Medtronic Sofamor Danek USA, Inc.

Technical Specification

510(k) Submission ID K210425
Product Code MAX
Medical Specialty / Panel Orthopedic
Regulation Citation 21 CFR 888.3080
Decision Date 2021-05-24
Clearance Pathway Traditional

Official Documentation

FDA CDRH Summary / statement of record

View FDA Summary PDF

Clearance Summary

Catalyft PL Expandable Interbody System received FDA 510(k) clearance under submission number K210425, sponsored by Medtronic Sofamor Danek USA, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Orthopedic review panel. The statutory decision date of record is 2021-05-24.

Classification & Regulation

This clearance is catalogued under FDA product code MAX and 21 CFR 888.3080, within the Orthopedic review panel as a Class II device.